Literature DB >> 11127542

Possible serotonin syndrome arising from an interaction between nortriptyline and selegiline in a lady with parkinsonism.

N P Hinds, C E Hillier, C M Wiles.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11127542     DOI: 10.1007/s004150070101

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

Review 1.  Depression in Parkinson's disease.

Authors:  Theresa A Zesiewicz; Robert A Hauser
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

Review 2.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

3.  Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline.

Authors:  Z Speiser; T Fine; L Litinetsky; S Eliash; E Blaugrund; S Cohen
Journal:  J Neural Transm (Vienna)       Date:  2007-09-07       Impact factor: 3.575

4.  An interesting case of serotonin syndrome precipitated by escitalopram.

Authors:  Debasish Sanyal; Suddhendu Chakraborty; Ranjan Bhattacharyya
Journal:  Indian J Pharmacol       Date:  2010-12       Impact factor: 1.200

5.  Case reports of neuroleptic malignant syndrome in context of quetiapine use.

Authors:  Mark B Detweiler; Kelly Sullivan; Taral R Sharma; Kye Y Kim; Jonna G Detweiler
Journal:  Psychiatr Q       Date:  2013-12

Review 6.  A Spanish Consensus on the Use of Safinamide for Parkinson's Disease in Clinical Practice.

Authors:  Javier Pagonabarraga; José Matías Arbelo; Francisco Grandas; Maria-Rosario Luquin; Pablo Martínez Martín; Mari Cruz Rodríguez-Oroz; Francesc Valldeoriola; Jaime Kulisevsky
Journal:  Brain Sci       Date:  2020-03-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.